Hyponatraemia and Clomipramine Therapy D. R. PLEDGER and H. MATHEW The fortuitous detection of SIADH is described in a patient receiving clomipramine therapy.
A wide variety of drugs have been implicated as causing hyponatraemia via the syndrome of inappropriate antidiuretic hormone secretion (SIADH) . No particular type of drug appears to be implicated and no mechanism has been elu cidated. A number of reports (Garson, 1979; Madahusoodanan & Osnos, 1981; Abbott, 1983) have implicated psychoactive drugs and most patients have been emergency admissions to hospital. We report a patient in whom the condition was fortuitously detected before this situation arose.
Case report
The patient wasa 64-year-oldmarried womanwith a long history (19years)of treatment for depressionand anxiety.
Previous treatment had included a range of benzodiazepine and tricycic drugs (Table I) . None of these, nor carba Initial serum electrolytesweremeasured on 22October and, following the finding of hyponatraemia, a repeat specimen was requested to confirm this finding (23 October). The course of biochemical measurements is charted in Table II. A provisionaldiagnosisof SIADHsecondaryto tricycic therapy was made and the patient was instructed to cease takingthe tricycic on 27October.The biochemicalpicture in the following two days appeared little improved and on closer questioning it appeared that the patient had been recommenced on clomipramine by the deputising service of thegeneral practitioner,who wasunawareofaposa'ble SIADH.
The importance of stopping this drug was again emphasised to the patient on 30 October and electrolyte levelsa week later showed a normal pattern.
One month later, the patient wasasymptomaticand not No definitive mechanism has been found for the syndrome, although a number of possibilities have been advanced: compulsive drinking of water seen in some psychotic patients (Sandifer, 1983) ; increased fluid intake to counter dryness of the mouth (possibly caused by the anticholinergic effects of neuroleptics) (Lewis, 1971) ; increased sphincter tonus of the urinary bladder; and a local anaesthetic effect and a central antidiuretic effect (Appel et a!, 1971 ).
The patient under discussion had previously been prescribed a number of drugs known to have this side-effect, without any apparent problems, although serum electrolytes had not been measured on these occasions. As these drugs had been taken for a long time, it is unlikely that serious hyponatraemia would have gone unnoticed. Apparent sensitivity to one particular drug (amitriptyline) has been recognised in this context previously (Madahusoodanan & Osnos, 1981) .
Although measurement of antidiuretic hormone was not made, the criteria for diagnosis of SIADH were met â€"¿ hyponatraemia, hypo-osmolality, lack of maximal urinary sodium retention and urinary osmolality greater than serum osmolality. These findings were not accompanied by evidence of volume depletion, cardiac failure, renal failure or hypothyroidism.
A previous case of SIADH on clomipramine was reported by Garson (1979) , whose patient was referred as an emergency by her family practitioner.
It was fortuitous that our patient had her electrolyte levels checked several days after clomipramine therapy had commenced, as there was no clinical indication of a problem at that time. A number of lessons stem from this case. The fact that a patient has not previously suffered electrolyte disturbance whilst on tricyclic therapy is no indication that this situation will appertain if the drug regime is altered.
As the initial symptoms of hyponatraemia (confusion, weakness, etc.) may mimic the psychi atric condition, clinical impression may not be a good guide. It is impossible to predict which patients will be
affected. An argument can be made for single measurement of serum and urine electrolyte levels on those patients whose symptoms are suggestive of possible SIADH following commencement or change of tricycic therapy. It is hoped that this will prevent the full sequalae of SIADH developing in patients at risk.
